Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Understanding fatigue after a first ischemic stroke

Official title: Better Understanding of Fatigue After STroke

Run by Brugmann University Hospital · NCT06292377 · Data updated 2026-11-12

This project will try to see if measures of heart rhythm, blood tests, and brain scans can explain why adults who recently had a first ischemic stroke develop ongoing fatigue.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorBrugmann University Hospital
Academic / other
Locations2 sites (Brussels and 1 other locations)
StatusRecruiting
StartedJune 7, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT06292377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) admitted to CHU Brugmann or UZ Brussel with a first-ever ischemic stroke within 72 hours who can undergo MRI and complete fatigue, cognitive, mood, and sleep assessments in French or Dutch.

Probably not a fit

People with prior strokes or other structural brain lesions, severe language impairment or dementia, life expectancy under one year, pregnancy, or who cannot speak French or Dutch are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with a first-ever ischemic stroke who are admitted within 72 hours to two Brussels stroke units will be enrolled and undergo ECG (for heart rate variability), transthoracic echocardiography, blood sampling, brain MRI, and standardized questionnaires for fatigue, cognition, mood, and sleep. The study will compare early (<3 months) and late (>3 months) post-stroke fatigue and relate symptom patterns to markers of autonomic dysfunction. Researchers will analyze whether altered heart rate variability and other biological markers correlate with persistent fatigue after stroke. No experimental drug or device is being tested; the focus is on physiological and clinical measurements to clarify underlying mechanisms.

Why it matters

Potential benefit: If successful, the findings could help identify patients at higher risk of post-stroke fatigue and point to new ways to prevent or treat it.

How similar studies have gone: Previous observational work has linked autonomic dysfunction and altered heart rate variability to worse post-stroke outcomes, but interventions to prevent or treat post-stroke fatigue based on these findings remain unproven, so the approach is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18
* First-ever (suspicion of) ischemic stroke based on clinical examination and/or brain imaging
* Onset \< 72h at time of inclusion
* Admitted at the stroke unit of CHU Brugmann and UZ Brussel
* Ability to participate in assessment of fatigue, cognitive, mood and sleep disturbances
* Ability to undergo MRI of the brain

Exclusion Criteria:

* Unable to speak French or Dutch
* Pre-existing stroke or other structural brain lesion
* Life expectancy \< 1 year
* Severe language impairment or dementia impeding assessment of fatigue, cognitive, mood and sleep disturbances
* Pregnancy or wish to become pregnant

Where it's running

  • CHU Brugmann
    Brussels, Belgium
    Recruiting
  • UZ Brussel
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.